Background Clostridium difficile is a leading cause of morbidity and mortality in several
countries. However, there are limited evidence characterizing its role as a global public …

Clostridium difficile is an anaerobic, Gram positive, spore-forming bacillus that is the leading
cause of nosocomial gastroenteritis. Clostridium difficile infection (CDI) is associated with …

Clostridium (reclassified as “Clostridioides”) difficile infection (CDI) is a healthcare-
associated infection and significant source of potentially preventable morbidity, recurrence …

Clostridioides difficile infection (CDI) is associated with increasing morbidity and mortality
posing an urgent threat to public health. Recurrence of CDI after successful treatment with …

Antibiotic resistance is one of the world's greatest public health challenges and adjunct
probiotic therapies are strategies that could lessen this burden. Clostridioides difficile …

Background The choice of antibiotics for systemic infections in patients with a high risk of
Clostridium difficile infection (CDI) remains a clinical practice dilemma. Although some …

Accurate and rapid antimicrobial susceptibility testing with pathogen identification in
bloodstream infections is critical to life results for early sepsis intervention. Advancements in …

ABSTRACT A clinically reflective model of the human colon was used to investigate the
effects of the broad-spectrum antibiotic omadacycline on the gut microbiome and the …

Objective: Antibiotics are widely used by all specialties in the hospital setting. We evaluated
previously defined high-risk antibiotic use in relation to Clostridioides difficile infections …

Background Antibiotic usage and antibiotic resistance (ABR) patterns changed during the
COVID-19 pandemic. Inadequate empiric antibiotic therapy (IET) is a significant public …